Skip to content

Retrospective study on association between vaginal microbiota and the histocompatibility of transvaginal pelvic polypropylene mesh

Association between vaginal microbiota and the histocompatibility of transvaginal pelvic polypropylene mesh

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15006038
Enrollment
Unknown
Registered
2015-03-04
Start date
2015-03-06
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic organ prolapse

Interventions

exposure group:no intervention
non-exposure group:no intervention

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Menopausal POP patients who have already accepted trans-vaginally placed mesh treatment.

Exclusion criteria

Exclusion criteria: 1. Patients with Diabetes and the blood glucose is not controlled under the target level; 2. Patients with immunological diseases and have been taking glucocorticoid hormone or anti-immunolgical drugs regularly; 3. Patients who had taken antibiotics or antifungal disease in latest 30 days; 4. Patients who had sexual life, trans-vaginally placed drug or vaginal lavage in the past 48 hours; 5. Patients who had bacterial vaginosis or sexually transmitted disease at the current visit; 6. Patients who had intrauterine device.

Design outcomes

Primary

MeasureTime frame
the structure and abundance of vaginal microbiota;

Countries

China

Contacts

Public ContactLan Zhu
zhu_julie@vip.sina.com13911714696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026